Association between inflammatory bowel disease and Parkinson's disease: Seek and you shall find?

Petra Weimers; Jonas Halfvarson; Michael C. Sachs; Jonas F. Ludvigsson; Inga Peter; Ola Olén; Johan Burisch

doi:10.1136/gutjnl-2018-316937

Association between inflammatory bowel disease and Parkinson's disease: Seek and you shall find?

Petra Weimers, Jonas Halfvarson, Michael C. Sachs, Jonas F. Ludvigsson, Inga Peter, Ola Olén, Johan Burisch

Research output: Contribution to journal › Letter › peer-review

16 Scopus citations

Original language	English
Pages (from-to)	175-176
Number of pages	2
Journal	Gut
Volume	68
Issue number	1
DOIs	https://doi.org/10.1136/gutjnl-2018-316937
State	Published - 1 Jan 2019

Keywords

epidemiology
inflammatory bowel disease

Access to Document

10.1136/gutjnl-2018-316937

Cite this

@article{6de8094ea95a4a9d999c162cad76c4ee,

title = "Association between inflammatory bowel disease and Parkinson's disease: Seek and you shall find?",

keywords = "epidemiology, inflammatory bowel disease",

author = "Petra Weimers and Jonas Halfvarson and Sachs, {Michael C.} and Ludvigsson, {Jonas F.} and Inga Peter and Ola Ol{\'e}n and Johan Burisch",

note = "Funding Information: Competing interests PW has received grants from Ferring l{\ae}gemidler and tillotts Pharma as well as non-financial support from Janssen-Cilag A/s, Calpro As, Pharmacosmos A/s and Vifor Pharma Nordiska AB. JH has received consulting or lecture fees from Abbvie, Celgene, Ferring, Hospira, Janssen, Medivir, MsD, Pfizer, renapharmaVifor, sandoz, shire takeda and tillotts Pharma research grants from Janssen, MsD and takeda. Karolinska Institutet has received fees for lectures held by OO on occasions organised by takeda and Ferring. Karolinska Institutet has received fees when OO participated as an expert in a panel discussing possibilities with register-based research. Karolinska Institutet (OO PI) performed an observational study, in part financed by an unrestricted grant from Janssen pharmaceuticals and one observational report financed by Pfizer. JB has received consulting fees from Celgene, Janssen-Cilag, Abbvie and Ferring, lecture fees from Abbvie, Pfizer, MsD and takeda and has received an unrestricted grant from takeda.",

year = "2019",

month = jan,

day = "1",

doi = "10.1136/gutjnl-2018-316937",

language = "English",

volume = "68",

pages = "175--176",

journal = "Gut",

issn = "0017-5749",

publisher = "BMJ Publishing Group",

number = "1",

}

TY - JOUR

T1 - Association between inflammatory bowel disease and Parkinson's disease

T2 - Seek and you shall find?

AU - Weimers, Petra

AU - Halfvarson, Jonas

AU - Sachs, Michael C.

AU - Ludvigsson, Jonas F.

AU - Peter, Inga

AU - Olén, Ola

AU - Burisch, Johan

N1 - Funding Information: Competing interests PW has received grants from Ferring lægemidler and tillotts Pharma as well as non-financial support from Janssen-Cilag A/s, Calpro As, Pharmacosmos A/s and Vifor Pharma Nordiska AB. JH has received consulting or lecture fees from Abbvie, Celgene, Ferring, Hospira, Janssen, Medivir, MsD, Pfizer, renapharmaVifor, sandoz, shire takeda and tillotts Pharma research grants from Janssen, MsD and takeda. Karolinska Institutet has received fees for lectures held by OO on occasions organised by takeda and Ferring. Karolinska Institutet has received fees when OO participated as an expert in a panel discussing possibilities with register-based research. Karolinska Institutet (OO PI) performed an observational study, in part financed by an unrestricted grant from Janssen pharmaceuticals and one observational report financed by Pfizer. JB has received consulting fees from Celgene, Janssen-Cilag, Abbvie and Ferring, lecture fees from Abbvie, Pfizer, MsD and takeda and has received an unrestricted grant from takeda.

PY - 2019/1/1

Y1 - 2019/1/1

KW - epidemiology

KW - inflammatory bowel disease

UR - http://www.scopus.com/inward/record.url?scp=85050249090&partnerID=8YFLogxK

U2 - 10.1136/gutjnl-2018-316937

DO - 10.1136/gutjnl-2018-316937

M3 - Letter

C2 - 30021791

AN - SCOPUS:85050249090

SN - 0017-5749

VL - 68

SP - 175

EP - 176

JO - Gut

JF - Gut

IS - 1

ER -